FBODaily.com | FedBizOpps: FILE | Q | Reference Labs - Attachment

FBO DAILY - FEDBIZOPPS ISSUE OF AUGUST 22, 2013 FBO #4289
DOCUMENT

Q -- Reference Labs - Attachment

Notice Date: 8/20/2013
Notice Type: Attachment
NAICS: 621511 — Medical Laboratories
Contracting Office: Department of Veterans Affairs;Network Contracting Office 20;5115 NE 82nd Ave, Suite 102;Vancouver WA 98662
ZIP Code: 98662
Solicitation Number: VA26013I1335
Response Due: 8/27/2013
Archive Date: 11/25/2013
Point of Contact: Dean Umathum
E-Mail Address: dean.umathum@va.gov
(Dean.Umathum@va.gov)
Small Business Set-Aside: N/A
Description: This is a SOURCES SOUGHT NOTICE for market research purposes only to determine the availability of potential businesses with capabilities to provide the services described below. Potential offerors are invited to provide feedback via e-mail to Dean Umathum at dean.umathum@va.gov. Responses will be used to determine the appropriate acquisition strategy for a potential future acquisition. The intended contract period is a one-year base period plus (4) four one-year option periods. Potential contractors shall provide, at a minimum, the following information to Dean Umathum at Dean.Umathum@va.gov. 1) Company name, address, point of contact name, phone number, e-mail address, and DUNS. 2) Is your firm eligible for participation in one of the following small business programs? If so, please indicate the program. Anticipated North American Industry Classification System (NAICS) code is 621511 - Medical Laboratories; the largest a firm can be and still qualify as a small business for Federal Government programs is no larger than $30.0 Million. [ ] yes [ ] no Small Business (SB) [ ] yes [ ] no HUBZone [ ] yes [ ] no Small Business 8(a) [ ] yes [ ] no Small Disadvantaged Business (SDB) [ ] yes [ ] no Women-Owned (WO) Small Business [ ] yes [ ] no Service Disabled Veteran Owned Small Business (SDVOSB) [ ] yes [ ] no Veteran Owned Small Business (VOSB) [ ] yes [ ] no Other (please specify) 3) How far away from Portland VAMC. 3710 SW Us Veterans Hospital Road, Portland OR 97239 4) Comment on any current or potential technical, cost, schedule, or performance risks that you would like to make the Government aware of that concern the draft statement of work below. (i.e., problems or any other issues experienced with similar contracts). Include comments on the Draft SOW. 5) How is the service, as described in the draft SOW typically priced? How could it be priced for a Government contract? 6) Provide a brief capability statement (Max 2 pages) with enough information to determine if your company can meet the requirement. The Capabilities Statement for this sources sought is not expected to be a Request for Quotations, Request for Proposals or Invitation for Bids, nor does it restrict the Government to an ultimate acquisition approach, but rather the Government is requesting a short statement regarding the company's ability to provide the services outlined in the draft SOW below. Any commercial brochures or currently existing marketing material may also be submitted with the capabilities statement. Submission of capabilities statement will assist our office in tailoring the requirement to be consistent with industry standards. The capabilities will be evaluated solely for the purpose of determining to Set-Aside for the Small Business (SB) Community or to conduct as an Unrestricted Procurement. Other than small businesses may respond to this notice in the event the market does not indicate SB interest. This synopsis is for information and planning purposes only and is not to be construed as a commitment by the Government. The Government will not pay for information solicited. Respondents will not be notified of the results of the evaluation. The DRAFT Statement of Work follows. Thank you for your participation. 1. Contract Title. Lab Testing 2. Background. Prior purchases used purchase card. This contract is required because Portland Path&Lab (PLMS) Portland VA Medical Center (PVAMC) needs reference lab services for these test developed and performed by Mayo Laboratories.. This test was developed and its performance characteristics determined by the Mayo Laboratory. Tests are only performed at Mayo. Although the tests may be listed on the test catalog of other labs, those labs will forward the specimen to Mayo for testing. These tests, listed below, will aid in the diagnosis of Veterans with diseases as listed. "FGF23 Fibroblast Growth Factor 23 (FGF23), Plasma oDiagnosing and monitoring oncogenic osteomalacia oPossible localization of occult neoplasms causing oncogenic osteomalacia oDiagnosing X-linked hypophosphatemia or autosomal dominant hypophosphatemic rickets oDiagnosing familial tumoral calcinosis with hyperphosphatemia oPredicting treatment response to calcitriol or vitamin D analogs in patients with renal failure "DLAU D-Lactate, Urine oDiagnosing D-lactate acidosis, especially in patients with jejunoileal bypass and short-bowel syndrome "AGA Alpha-Galactosidase, Leukocytes oDiagnosis of Fabry disease in males oVerifying abnormal serum alpha-galactosidase results in males with a clinical presentation suggestive of Fabry disease "EHRL Ehrlichia/Anaplasma, Molecular Detection, PCR, Blood oEvaluating patients suspected of acute anaplasmosis or ehrlichiosis "FIRGH Growth Hormone-Releasing Hormone (GH-RH) oGrowth Hormone Releasing Hormone is a 44 amino acid peptide produced primarily by the hypothalamus. It isi a neurohumoral control for adenohypophyseal secretion of Growth Hormone. Other hypothalamic hormones have a stimulatory effect on pituitary hormones, but Growth Hormone Releasing Hormone has no known effect on other pituitary hormones. Somatostatin is the inhibitory counterpart of Growth Hormone Releasing Hormone. Growth Hormone Releasing Hormone has structural similarities with the Secretin-Glucagon family of gastrointestinal hormones. Growth Hormone Releasing Hormone has been isolated from pancreatic islet cells and various cancer tumor cells. "P50 Oxygen Dissociation, P50, Erythrocytes oIdentifying hemoglobin variants associated with polycythemias "PAVAL Paraneoplastic Autoantibody Evaluation, Serum oSerological evaluation of patients who present with a subacute neurological disorder of undetermined etiology, especially those with known risk factors for cancer oDirecting a focused search for cancer oInvestigating neurological symptoms that appear in the course of, or after, cancer therapy, and are not explainable by metastasis oDifferentiating autoimmune neuropathies from neurotoxic effects of chemotherapy oMonitoring the immune response of seropositive patients in the course of cancer therapy oDetecting early evidence of cancer recurrence in previously seropositive patients "PIPA Pipecolic Acid, Serum oDifferential diagnosis between disorders of peroxisomal biogenesis (eg, Zellweger syndrome) and disorders with loss of a single peroxisomal function oAbnormal elevations of pipecolic acid can be detected in either serum or urine "FQPPS Porphyrins, Feces oEvaluation of persons who present with signs or symptoms suggestive of porphyria cutanea tarda, hereditary coproporphyria, variegate porphyria, congenital erythropoietic porphyria, or erythropoietic protoporphyria "SGSU Synthetic Glucocorticoid Screen, Urine oConfirming the presence of the listed synthetic glucocorticoids (see Interpretation) oConfirming the cause of secondary adrenal insufficiency oThis assay does not detect fluticasone propionate. "UPGDW Uroporphyrinogen Decarboxylase (UPG D), Washed Erythrocytes oDiagnosis of porphyria cutanea tarda type II and hepatoerythropoietic porphyria 3. Scope. This is for the PLMS PVAMC which sends out patient specimens regularly throughout the year. Base year plus 4 option years 4. Specific Tasks. The Reference Laboratory shall provide in accordance with all applicable federal, state, and local regulations, laws, and ordinances, and in accordance with the specifications outlined for accreditation certification if applicable, patient specimen testing for the tests listed below. Reference lab will provide the test results to PLMS PVAMC. All requirements and provisions defined in the specification of this solicitation will apply to any laboratory, i.e. branch, division, sub-contractor, etc. performing reference testing on behalf of the Reference Laboratory. TestQntyunits est price extended price Alpha-Galactosidase, Leukocyte9EA D-Lactate9EA Ehrlichia / Anaplasma, PCR9EA Fibroblast Growth Factor 23, P9EA Growth Hormone Releasing Hormone9EA Oxygen Dissociation, P50 RBC9EA Paraneoplastic Autoantibody Eval, Serum9EA Pipecolic Acid, Serum9EA Porphyrins, Fecal Panel9EA Synthetic Glucocorticoid Screen, U9EA Upg D Erythrocytes9EA total 5. Performance Monitoring COTR will verify services. 6. Security Requirements. The reference laboratory shall fax test results to PLMS PVAMC. 7. Government-Furnished Equipment (GFE)/Government-Furnished Information (GFI). NA 8. Other Pertinent Information or Special Considerations. NA a. Identification of Possible Follow-on Work. NA b. Identification of Potential Conflicts of Interest (COI). NA c. Identification of Non-Disclosure Requirements. NA d. Packaging, Packing and Shipping Instructions. NA. e. Inspection and Acceptance Criteria. See performance monitoring 9. Risk Control. NA 10. Place of Performance. Reference Laboratory 11. Period of Performance. Start October 2013 through 30 Sep 2014, with 4 option years 12. Delivery and Pick-up Schedule. Deliver tests results from tests listed in paragraph 5 ordered to PLMS PVAMC via fax. DISCLAIMER This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.
Web Link: FBO.gov Permalink
(https://www.fbo.gov/notices/d73e0bf741a7e04d63ef192dfc0291c1)
Document(s): Attachment; File Name: VA260-13-I-1335 VA260-13-I-1335.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=957610&FileName=VA260-13-I-1335-000.docx); Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=957610&FileName=VA260-13-I-1335-000.docx; Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
Place of Performance: Address: Portland VA Medical Center;3710 SW US Veterans Hospital Road;Portland, OR; Zip Code: 97239
Record: SN03155725-W 20130822/130821000040-d73e0bf741a7e04d63ef192dfc0291c1 (fbodaily.com)
Source: FedBizOpps Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |

Loren Data's SAM Daily™

Q -- Reference Labs - Attachment